Immunological and molecular study in children with combined immunodeficiency

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a group of primary immunodeficiencies (PID) resulting from molecular defects affecting lymphocyte development and function.
• Timely diagnosis and intervention are critical for achieving disease-free survival in SCID patients.
• This study focuses on identifying genetic defects in Egyptian pediatric patients presenting with SCID-like symptoms.

Purpose of the Study:

• To investigate potential genetic causes of SCID in Egyptian infants and children.
• To identify specific gene mutations or variants contributing to the immunodeficiency phenotype.

Main Methods:

• Eighty patients with clinical signs of immunodeficiency were evaluated.
• Immunological assessment included serum immunoglobulin levels and flow cytometry for immune cell subsets.
• DNA sequencing of the RAG1 and RAG2 genes was performed on patients with altered immune profiles.

Main Results:

• Eighteen out of thirty patients with abnormal immune profiles showed variants in the RAG1 and RAG2 genes.
• Identified variants include both novel and previously reported mutations and polymorphisms in RAG1 (e.g., E880K, H249R) and RAG2 (e.g., P501T, rs10836573).

Conclusions:

• Mutation gene analysis is essential for a comprehensive evaluation of SCID patients.
• Identifying genetic defects aids in accurate diagnosis and guides appropriate management strategies for SCID.